While older anti-obesity drugs may lead to less weight loss than semaglutide and tirzepatide, they remain useful tools in ...

The nature of the beast is yes, these drugs come off patent; the demand is there and someone could produce it more cheaply’, Integral Asset Management’s Keith McLachlan points out.

Medically reviewed by Maggie Moon, MS, RD Your diet plays a significant role in your heart health. Some foods, like processed ...

Choosing high-protein snacks can keep you full between meals, support blood sugar regulation, and promote a healthy body ...

To make it easier to ingest, mix one tablespoon of granulated sweeteners ... should not be treated with dietary changes. Injectable glucagon can treat severely low levels. People with severely ...

A new review highlights the future of anti-obesity medications that could outperform today's already blockbuster drugs like Ozempic.

Mounjaro can cause mild to moderate side effects, such as nausea, vomiting, constipation, and indigestion. According to Eli ...

Add into the mix Mounjaro, and there's arguably even more ... a dual glucose-dependent insulinotropic polypeptide, or GIP, and glucagon-like peptide-1 (GLP-1) receptor agonist.